Anavex Life Sciences Corp. ("Anavex" or the "Company") (OTCQB: AVXL) has announced that the current issue of the peer-reviewed scientific journal PLOS ONE explains that sigma-1 receptor (Sig-1R) activity is involved in cellular survival by regulating and stabilizing a key cell stress sensor. These findings may explain the therapeutic efficacy of Sig-1R agonists like ANAVEX 2-73 in Alzheimer's disease and other neurodegenerative disorders...
No comments:
Post a Comment